Respiratory Microbiome and COPD Exacerbations (RESMECOPD)

Clinical trial NCT03432234 · UNKNOWN

Trial details

NCT number: NCT03432234
Sponsor: Corporacion Parc Tauli
Status: UNKNOWN
Study type: OBSERVATIONAL

Pulmonary Disease, Chronic Obstructive Exacerbation COPD

Start date: 2016-03-07
Primary completion: 2018-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.